Stock DNA
Chemicals & Petrochemicals
USD 2,441 Million (Small Cap)
7.00
NA
0.00%
10.26
172.03%
20.22
Total Returns (Price + Dividend) 
Ingevity Corp. for the last several years.
Risk Adjusted Returns v/s 
News

Ingevity Corp. Experiences Revision in Stock Evaluation Amidst Market Dynamics
Ingevity Corp., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its evaluation amid current market conditions. The stock has shown resilience with a notable annual return, while technical indicators present a mixed performance, reflecting both bullish and bearish sentiments. The company's price action highlights its volatility and ability to adapt to market changes.
Read MoreIs Ingevity Corp. technically bullish or bearish?
As of 24 October 2025, the technical trend for Ingevity Corp. has changed from mildly bullish to bullish. The current stance is bullish, driven by daily moving averages indicating bullish momentum, and both weekly and monthly Bollinger Bands also signaling bullish conditions. However, the MACD shows a mildly bearish signal on the weekly timeframe, which slightly tempers the overall bullish outlook. In terms of performance, Ingevity has outperformed the S&P 500 significantly over the past year, returning 77.49% compared to the S&P 500's 16.90%, and has also shown strong returns year-to-date at 40.29% versus 15.47% for the benchmark....
Read MoreIs Ingevity Corp. technically bullish or bearish?
As of 24 October 2025, the technical trend for Ingevity Corp. has changed from mildly bullish to bullish. The daily moving averages indicate a bullish stance, while the weekly and monthly Bollinger Bands also support a bullish outlook. However, the MACD shows a mildly bearish signal on the weekly timeframe, which contrasts with the mildly bullish signal on the monthly timeframe. The KST and Dow Theory are both mildly bullish across both weekly and monthly periods, and the OBV is also mildly bullish. Overall, the indicators suggest a bullish stance, albeit with some mixed signals in the weekly MACD. Multi-period return data is not available for comparison with the S&P 500....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 86 Schemes (63.58%)
Held by 121 Foreign Institutions (10.8%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 28.63% vs -4.92% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -814.63% vs 23.49% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -16.92% vs 1.59% in Dec 2023
YoY Growth in year ended Dec 2024 is -7,868.52% vs -102.55% in Dec 2023






